|
Monday, 30 Jul 2007
Surgical resection of the affected liver offers the best chance for disease-free survival in patients with Hepatoma (HCC). Unfortunately, most hepatoma patients present with disease which is multi-focal and thus not resectable. Fewer than 15% of HCC patients are resectable. The objective of treatment with TheraSphere is to selectively administer a dose of radioactive material directly to neoplastic tissue in the liver. Systemic therapy is largely ineffective. [read more]
|
|
|
|
|
|
|
Monday, 30 Jul 2007
This phase II trial is studying how well internal radiation therapy works in treating patients with liver metastases from neuroendocrine tumors. [read more]
|
|
|
|
|
|
|
Monday, 30 Jul 2007
This study is for people with cancer of the liver that cannot be completely removed by surgery. This study involves giving the drugs mitomycin-C and cisplatin, into an artery in the liver. [read more]
|
|
|
|
|
|
|
Monday, 30 Jul 2007
The purpose of this study is to determine the maximum tolerated dose (MTD) of ThermoDox when used in combination with radiofrequency ablation (RFA) in the treatment of primary and metastatic tumors of the liver. [read more]
|
|
|
|
|
|
|
Monday, 30 Jul 2007
The purpose of this study is to provide supervised access to treatment with TheraSphere® to eligible patients with primary and metastatic cancer and evaluate response to treatment, survival and toxicity. [read more]
|
|
|
|
|
|
|
Monday, 30 Jul 2007
This phase II trial is studying the side effects and how well giving internal radiation therapy and external radiation therapy together with fluorouracil works in treating patients with newly diagnosed or recurrent pancreatic cancer and liver metastases that cannot be removed by surgery. [read more]
|
|
|
|
|
|
|
Monday, 30 Jul 2007
The main purpose of this study is to determine the effect of treatment with SIR-Spheres® on the overall survival of patients with primary liver cancer or hepatocellular carcinoma (HCC). [read more]
|
|
|
|
|
|
|
Monday, 30 Jul 2007
A double arm (non-inferiority) 44 patient study to assess the performance of BeadBlock™ in the treatment of uterine fibroids by embolization with respect to clinical & imaging outcome with comparison of primary safety endpoints to Embosphere. [read more]
|
|
|
|
|
|
|
Monday, 30 Jul 2007
This randomized phase II trial is studying to see if chemoembolization followed by bevacizumab works better than chemoembolization alone in treating patients who have liver cancer that cannot be removed with surgery. [read more]
|
|
|
|
|
|
|
Monday, 30 Jul 2007
This phase II trial is studying how well giving bevacizumab together with chemoembolization works in treating patients with liver cancer that cannot be removed by surgery. [read more]
|
|
|
|
|
